Related Experiment Video

Updated: Dec 31, 2025

Morphological and Functional Assessment of the Right Ventricle Using 3D Echocardiography
07:11

Morphological and Functional Assessment of the Right Ventricle Using 3D Echocardiography

Published on: October 28, 2020

3.2K

Significance of left ventricular hypertrophy in cardiovascular morbidity and mortality

E Kaplinsky1

  • 1Heart Institute, Sheba Medical Center, Tel-Hashomer, Israel.

Cardiovascular Drugs and Therapy
|August 1, 1994
PubMed

Insights

Left ventricular hypertrophy (LVH) independently increases mortality risk after myocardial infarction. Patients with LVH experienced doubled 1- and 5-year mortality rates, highlighting its prognostic significance.

Area of Science:

  • Cardiology
  • Internal Medicine
  • Pathophysiology

Background:

  • Left ventricular hypertrophy (LVH) is traditionally linked to hemodynamic factors.
  • LVH is an independent risk factor for adverse cardiovascular outcomes.
  • Its presence in various conditions, including obesity and aging, underscores its prognostic importance.

Purpose of the Study:

  • To investigate the long-term impact of LVH on mortality in myocardial infarction survivors.
  • To assess LVH as an independent prognostic indicator in post-myocardial infarction patients.

Main Methods:

  • Analysis of patients surviving myocardial infarction from the SPRINT database.
  • Evaluation of long-term mortality (mean 5.5 years) in relation to electrocardiogram-detected LVH (ECG-LVH).

Main Results:

  • Patients with ECG-LVH were older and had more in-hospital complications.
  • The 1- and 5-year mortality rates were doubled in patients with ECG-LVH compared to those without.
  • LVH is associated with significant increases in risk for patients with hypertensive or coronary artery disease.

Conclusions:

  • LVH is a significant independent predictor of long-term mortality post-myocardial infarction.
  • Mechanisms include cardiac fibrosis, impaired function, and abnormal electrophysiology.
  • Regression of LVH through treatment may improve prognosis, requiring further investigation.

More Related Videos

Biventricular Assessment of Cardiac Function and Pressure-Volume Loops by Closed-Chest Catheterization in Mice08:21

Biventricular Assessment of Cardiac Function and Pressure-Volume Loops by Closed-Chest Catheterization in Mice

Published on: June 15, 2020

4.8K
Scanning Electron Microscopy of Macerated Tissue to Visualize the Extracellular Matrix10:21

Scanning Electron Microscopy of Macerated Tissue to Visualize the Extracellular Matrix

Published on: June 14, 2016

10.5K

Related Concept Videos

Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
310
Heart Failure II: Pathophysiology01:29

Heart Failure II: Pathophysiology

Systolic Heart Failure and Compensatory MechanismsSystolic heart failure (also termed HFrEF, Heart Failure with Reduced Ejection Fraction) is the most prevalent type of heart filure. It results in a decreased volume of blood being pumped from the ventricle. The aortic arch and carotid sinuses have baroreceptors that detect reduced blood pressure, triggering the sympathetic nervous system (SNS) to release epinephrine and norepinephrine. Initially, this response aims to boost heart rate and...
607
Mitral Stenosis I: Introduction01:22

Mitral Stenosis I: Introduction

Mitral Valve Stenosis (MVS) is a heart condition where the mitral valve narrows, impeding blood circulation from the left atrium to the left ventricle. The etiology and pathophysiology of this condition are multifaceted, leading to a cascade of cardiovascular complications.Causes of Mitral Valve StenosisRheumatic Heart Disease: It is the main cause of mitral valve stenosis, particularly in developing nations. This condition arises from rheumatic fever, an inflammatory illness resulting from...
333
Mitral Regurgitation I: Introduction01:20

Mitral Regurgitation I: Introduction

Mitral regurgitation is characterized by the backward circulation of blood from the left ventricle to the left atrium during systole, a phase of the cardiac cycle when the heart contracts and pumps blood out of the chambers. This abnormal flow occurs primarily due to the dysfunction of the mitral valve or its supporting structures, which include the mitral leaflets, chordae tendineae, annulus, and papillary muscles.Etiology and Mechanisms:Primary Mitral Regurgitation: This type arises from...
315
Imbalances in Cardiac Output01:26

Imbalances in Cardiac Output

The heart's primary function is to pump blood throughout the body, maintaining a balance between blood sent out (cardiac output) and blood returning (venous return). If this balance is disrupted, it can result in congestive heart failure (CHF), a severe condition where the heart becomes an inefficient pump, leading to inadequate blood circulation.
CHF can occur due to the failure of either side of the heart. Left-side failure leads to pulmonary congestion—the right side continues to send...
2.2K
Pathophysiology of Heart Failure01:17

Pathophysiology of Heart Failure

Heart failure (HF) is a progressive syndrome involving ventricles that leads to inadequate cardiac output. It can be classified based on location and output or ejection fraction. Ejection fraction (EF) is an essential measurement in the diagnosis and surveillance of HF. Reduced EF corresponds to systolic heart failure (HFrEF). However, HF with preserved ejection fraction (HFpEF) is becoming increasingly prevalent. Also known as diastolic HF, this form of HF is related to aging. The...
2.6K